Year archive

CF PharmTech — 2026 filings

All 2 regulatory filings released by CF PharmTech (2652) in 2026, sourced directly from the official regulator.

2 Filings

2026 Period

2026 filings (2)

Filing	Released	Lang
Major Milestone CF PHARMTECH, INC. 2652.HK Announces IND Acceptance for PAH New Drug with a Globally Innovative Improved Mechanism, Marking Another Milestone for Its Precision Drug Delivery Platform Regulatory Filings	2026-03-16	English
CF PharmTech (HKEX: 2652.HK) Announces NMPA Acceptance of IND Application for ICF004, a Potential First-in-Class Inhaled Dry Powder Candidate Targeting Unmet Needs in PF-ILD Regulatory Filings	2026-02-25	English